We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+0.23%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$36.6B
AUM Growth
+$542M
Cap. Flow
+$871M
Cap. Flow %
2.38%
Top 10 Hldgs %
24.82%
Holding
990
New
258
Increased
273
Reduced
319
Closed
82

Top Buys

Rank Stock Value
1
AA.PRB
Alcoa Inc
AA.PRB
+$248M
2
ORCL icon
Oracle
ORCL
+$188M
3
QCOM icon
Qualcomm
QCOM
+$139M
4
META icon
Meta Platforms (Facebook)
META
+$130M
5
AMZN icon
Amazon
AMZN
+$124M

Sector Composition

Rank Sector Weight
1 Technology 19.55%
2 Healthcare 12.56%
3 Financials 12.39%
4 Consumer Discretionary 11.97%
5 Communication Services 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
51
Apple
AAPL
$4.56T
$121M 0.33%
3,860,776
-8,028
-0.2% -$257K
BHC icon
52
Bausch Health
BHC
$2.26B
$121M 0.33%
543,215
-1,014
-0.2% -$225K
C icon
53
Citigroup
C
$227B
$121M 0.33%
2,181,807
-62,778
-3% -$3.42M
GWR
54
DELISTED
Genesee & Wyoming Inc.
GWR
$105M 0.29%
1,376,939
+73,631
+6% +$6.48M
CAG icon
55
Conagra Brands
CAG
$7.14B
$105M 0.29%
3,079,150
GHL
56
DELISTED
Greenhill & Co., Inc.
GHL
$101M 0.28%
2,453,947
+227,231
+10% +$9.19M
TRV icon
57
Travelers Companies
TRV
$80.1B
$101M 0.28%
1,045,307
+27,673
+3% +$2.83M
DD icon
58
DuPont de Nemours
DD
$19.8B
$98.9M 0.27%
763,471
+24,325
+3% +$3.15M
TDG icon
59
TransDigm Group
TDG
$69.6B
$97.8M 0.27%
435,216
+14,597
+3% +$3.27M
MDLZ icon
60
Mondelez International
MDLZ
$80.1B
$97.1M 0.27%
2,359,095
+220,581
+10% +$8.65M
PFE icon
61
Pfizer
PFE
$148B
$96.4M 0.26%
3,030,378
-322,089
-10% -$10.5M
FITB
62
Fifth Third Bancorp
FITB
$52.1B
$95.4M 0.26%
4,582,198
-278,976
-6% -$5.65M
VZ icon
63
Verizon
VZ
$195B
$91.7M 0.25%
1,966,523
-60,129
-3% -$2.94M
MET icon
64
MetLife
MET
$63.8B
$89.6M 0.24%
1,795,165
-59,219
-3% -$2.8M
KMI icon
65
Kinder Morgan
KMI
$69.2B
$87M 0.24%
2,266,297
+121,255
+6% +$5.06M
CVS icon
66
CVS Health
CVS
$123B
$85.6M 0.23%
815,976
-99,170
-11% -$10.1M
EMC
67
DELISTED
EMC CORPORATION
EMC
$82.6M 0.23%
3,130,539
-51,034
-2% -$1.36M
BKNG icon
68
Booking.com
BKNG
$156B
$82.3M 0.22%
1,786,300
-37,200
-2% -$1.77M
QVCGA
69
DELISTED
QVC Group Inc Series A
QVCGA
$80.2M 0.22%
59,511
-2,325
-4% -$3.23M
LLY icon
70
Eli Lilly
LLY
$1.05T
$78.7M 0.22%
943,019
-180,316
-16% -$13.7M
HCA icon
71
HCA Healthcare
HCA
$88.2B
$76.9M 0.21%
847,657
+12,206
+1% +$978K
ALXN
72
DELISTED
Alexion Pharmaceuticals
ALXN
$75.8M 0.21%
+419,324
New +$72.4M
SBNY
73
DELISTED
Signature Bank
SBNY
$74.2M 0.2%
506,948
+91
+0% +$12.6K
SNY icon
74
Sanofi
SNY
$104B
$71.7M 0.2%
1,446,627
-91,084
-6% -$4.62M
BDC icon
75
Belden
BDC
$5.11B
$71.4M 0.2%
879,383
-4,151
-0.5% -$364K

Similar funds

Loomis, Sayles & Company's Q2 2015 Portfolio in Review

As of Q2 2015, Loomis, Sayles & Company held 990 positions worth $36.6B, up 1.5% from $36.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Loomis, Sayles & Company's Q2 2015 filing shows 258 new, 273 increased, 319 reduced and 82 closed positions. Its largest new stake was Alexion Pharmaceuticals: 419,324 shares worth $75.8M. The largest sale was PPG Industries, an estimated $666M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Loomis, Sayles & Company's largest Q2 2015 buy was Alexion Pharmaceuticals: 419,324 shares worth $75.8M.
  • Loomis, Sayles & Company added most to Alcoa Inc in Q2 2015, an estimated $248M increase.
  • Loomis, Sayles & Company's biggest Q2 2015 reduction was PPG Industries, cutting an estimated $666M.
  • Loomis, Sayles & Company fully exited AOL INC COMMON STOCK in Q2 2015, selling an estimated $40.1M.
  • Loomis, Sayles & Company's ten largest holdings make up 25% of its $36.6B portfolio in Q2 2015.
  • Loomis, Sayles & Company opened 258 new positions and closed 82 in Q2 2015.
  • Loomis, Sayles & Company's portfolio value rose 1.5% quarter-over-quarter to $36.6B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2015, filed 14 Aug 2015.